Tandem Diabetes Care, Inc. (TNDM) FY2026 Q2 P&L / Income Statement

Tandem Diabetes Care, Inc. (TNDM) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Sales

254,560,000 US dollars

Cost of sales

109,780,000 US dollars

Gross profit

144,780,000 US dollars

Total operating expenses

158,572,000 US dollars

Operating loss

negative 13,792,000 US dollars

Other income (expense), net (calculated)

negative 6,866,000 US dollars

Loss before income taxes

negative 20,658,000 US dollars

Income tax expense (benefit)

510,000 US dollars

Net loss

negative 21,168,000 US dollars

UNITED STATES

179,292,000 US dollars

International

75,268,000 US dollars

Selling, general and administrative

111,642,000 US dollars

Research and development

46,930,000 US dollars

Acquired in-process research and development expenses

0 US dollars

Litigation and settlement expense

0 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.